Every order ships with a signed COACrypto checkout — 10% off

For research use only — not for human or veterinary consumption.

Reference-grade research compound

Survodutide

Survodutide (BI 456906); a fatty-acid-acylated 29-residue glucagon/GLP-1 receptor dual-agonist peptide

+13 more residues

Schematic — no PDB structure deposited

Scientific name
Survodutide (BI 456906); a fatty-acid-acylated 29-residue glucagon/GLP-1 receptor dual-agonist peptide
Sequence
Length
29-mer
Molecular formula
C192H289N47O61
Molecular weight
4231.69 g/mol
Form
lyophilized
Vial size
10 mg
Storage
Store lyophilized powder at −20 °C, desiccated and protected from light. Stable for 24 months.
Batch HPLC purity
99.0%

Description

Acylated 29-residue peptide based on glucagon, incorporating non-natural residues and a C18 fatty-diacid side chain, acting at both glucagon and GLP-1 receptors. Used in vitro as a reference compound in dual-receptor cAMP signaling assays and metabolic cell-line model systems. Supplied as a lyophilized acetate salt.

Current batch

RR-SURVODUTIDE-260405-B

Manufactured Apr 5, 2026

Tested Apr 11, 2026

Download COA (PDF)
Reverse-phase HPLC · UV 220 nm · Batch RR-SURVODUTIDE-260405-BMain peak 99.0%
0.000.250.500.751.0003691215

Storage and stability

Store lyophilized powder at −20 °C, desiccated and protected from light. Stable for 24 months.

Peer-reviewed references

Titles and journals pulled from PubMed and cached for 7 days. Links open in a new tab.